Teligent, Inc. (TLGT)
TLGTPrice: $0.17
Fair Value: 🔒
🔒score
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical produc... more
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under ... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Timothy Sawyer |
| IPO Date | 1981-07-30 | CAGR | 0.03% |
| Employees | 142 | Website | www.teligent.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TLGT chart loading...
Fundamentals
Technicals
| Enterprise Value | $144.32M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-4.31 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -16.53% | Gross Margin | -0.08% |
| Operating Margin | -3.09% | Profit Margin | -2.69% |
| ROE | 2.11% | ROA | -1.39% |
| ROCE | -2.16% | Current Ratio | 1.92 |
| Quick Ratio | 0.9 | Cash Ratio | 0.26 |
| Debt/Equity | -1.48 | Interest Coverage | — |
| Altman Z Score | — | Piotroski Score | — |